Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 09 Mar 2021

HLC Pair Suppression as a Risk Factor for Bacterial Bloodstream Infections and Early Mortality in Newly Diagnosed Intact Immunoglobulin Multiple Myeloma Patients

in Hematologic Malignancies

Jose Luis Garcia de Veas Silva
Maria Trinidad Gonzalez Cejudo
Alberto Garcia Perojil Jimenez
Maria del Señor Garcia Lopez Velez
Rafael Garcia Rios Tamayo
Carmen Garcia Bermudo Guitarte
Tomas Garcia De Haro Muñoz

Frontiers in Oncology

doi 10.3389/fonc.2021.599532

3,889 views
6 citations

Original Research

Published on 08 Mar 2021

Clinical Features and Prognoses of IgG4-Positive and IgG4-Negative Lacrimal Lymphomas

in Hematologic Malignancies

Rui Liu
Jinjin Wang
Nan Wang
Jing Li
Xin Ge
Jingxue Zhang
Jianmin Ma

Frontiers in Oncology

doi 10.3389/fonc.2021.622847

3,129 views
7 citations

Original Research

Published on 05 Mar 2021

Circulating Plasma Cells as a Biomarker to Predict Newly Diagnosed Multiple Myeloma Prognosis: Developing Nomogram Prognostic Models

in Hematologic Malignancies

Qianwen Cheng
Li Cai
Yuyang Zhang
Lei Chen
Yu Hu
Chunyan Sun

Frontiers in Oncology

doi 10.3389/fonc.2021.639528

5,933 views
24 citations

Original Research

Published on 05 Mar 2021

Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma

in Hematologic Malignancies

Peifeng Li
Jia Chai
Zi Chen
Yang Liu
Jie Wei
Yixiong Liu
Danhui Zhao
Jing Ma
Kaijing Wang
Xia Li

Frontiers in Oncology

doi 10.3389/fonc.2021.622648

10,799 views
21 citations

Original Research

Published on 05 Mar 2021

Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey

in Hematologic Malignancies

Uros Markovic
Alessandra Romano
Vittorio Del Fabro
Claudia Bellofiore
Anna Bulla
Marina Silvia Parisi
Salvatore Leotta
Massimo Gentile
Clotilde Cangialosi
Iolanda Vincelli

Frontiers in Oncology

doi 10.3389/fonc.2021.624405

8,478 views
11 citations

Original Research

Published on 05 Mar 2021

Prognostic Relevance of Expression of EMP1, CASP1, and NLRP3 Genes in Pediatric B-Lineage Acute Lymphoblastic Leukemia

in Hematologic Malignancies

Jay Singh
Sarita Kumari
Mohit Arora
Deepak Verma
Jayanth Kumar Palanichamy
Rajive Kumar
Gunjan Sharma
Sameer Bakhshi
Deepam Pushpam
M. Shadab Ali

Frontiers in Oncology

doi 10.3389/fonc.2021.606370

6,386 views
14 citations

Case Report

Published on 04 Mar 2021

Case Report: Asymmetric Bone Marrow Involvement in Patients With Acute Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

in Hematologic Malignancies

Han Yan
Zhenyang Zhou
Yingying Wu
Zhaodong Zhong
Yong You
Junxia Yao
Wanxin Chen
Linghui Xia
Xiaotian Xia
Wei Shi

Frontiers in Oncology

doi 10.3389/fonc.2021.626018

4,235 views
2 citations

Systematic Review

Published on 04 Mar 2021

Clinical Value of ctDNA in Hematological Malignancies (Lymphomas, Multiple Myeloma, Myelodysplastic Syndrome, and Leukemia): A Meta-Analysis

in Hematologic Malignancies

Xiangyu Tan
Han Yan
Lei Chen
Yuyang Zhang
Chunyan Sun

Frontiers in Oncology

doi 10.3389/fonc.2021.632910

6,216 views
10 citations

Original Research

Published on 03 Mar 2021

Comparison of Two Strategies for Prophylactic Donor Lymphocyte Infusion in Patients With Refractory/Relapsed Acute Leukemia

in Hematologic Malignancies

Qiongqiong Su
Zhiping Fan
Fen Huang
Na Xu
Danian Nie
Dongjun Lin
Ziwen Guo
Pengcheng Shi
Zhixiang Wang
Ling Jiang

Frontiers in Oncology

doi 10.3389/fonc.2021.554503

2,991 views
9 citations

Original Research

Published on 02 Mar 2021

High Expression of CLEC11A Predicts Favorable Prognosis in Acute Myeloid Leukemia

in Hematologic Malignancies

Chengliang Yin
Junyan Zhang
Wei Guan
Liping Dou
Yuchen Liu
Ming Shen
Xiaodong Jia
Lu Xu
Rilige Wu
Yan Li

Frontiers in Oncology

doi 10.3389/fonc.2021.608932

5,473 views
18 citations

Brief Research Report

Published on 26 Feb 2021

Antinuclear Antibodies With a Nucleolar Pattern Are Associated With a Significant Reduction in the Overall Survival of Patients With Leukemia: A Retrospective Cohort Study

in Hematologic Malignancies

Rong Wang
Huijuan Zhao
Yang Liu
Bing Kang
Jun Cai

Frontiers in Oncology

doi 10.3389/fonc.2021.631038

120,153 views
10 citations

Case Report

Published on 26 Feb 2021

Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia

in Hematologic Malignancies

Benoît Brethon
Elodie Lainey
Aurélie Caye-Eude
Audrey Grain
Odile Fenneteau
Karima Yakouben
Julie Roupret-Serzec
Lou Le Mouel
Hélène Cavé
André Baruchel

Frontiers in Oncology

doi 10.3389/fonc.2021.637951

5,958 views
23 citations

Original Research

Published on 26 Feb 2021

Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms

in Hematologic Malignancies

Jacob Handlos Grauslund
Morten Orebo Holmström
Nicolai Grønne Jørgensen
Uffe Klausen
Stine Emilie Weis-Banke
Daniel El Fassi
Claudia Schöllkopf
Mette Borg Clausen
Lise Mette Rahbek Gjerdrum
Marie Fredslund Breinholt

Frontiers in Oncology

doi 10.3389/fonc.2021.637420

10,690 views
49 citations

Clinical Trial

Published on 26 Feb 2021

Haploidentical Stem Cell Transplantation With a Novel Conditioning Regimen in Older Patients: A Prospective Single-Arm Phase 2 Study

in Hematologic Malignancies

Yu-Qian Sun
Ting-Ting Han
Yu Wang
Chen-Hua Yan
Feng-Rong Wang
Zhi-Dong Wang
Jun Kong
Yu-Hong Chen
Huan Chen
Wei Han

Frontiers in Oncology

doi 10.3389/fonc.2021.639502

6,404 views
24 citations

Review

Published on 25 Feb 2021

Evolving Chemotherapy Free Regimens for Acute Promyelocytic Leukemia

in Hematologic Malignancies

Uday Kulkarni
Vikram Mathews

Frontiers in Oncology

doi 10.3389/fonc.2021.621566

8,773 views
11 citations

Review

Published on 25 Feb 2021

Hypomethylating Agents and Immunotherapy: Therapeutic Synergism in Acute Myeloid Leukemia and Myelodysplastic Syndromes

in Hematologic Malignancies

Kah Keng Wong
Rosline Hassan
Nik Soriani Yaacob

Frontiers in Oncology

doi 10.3389/fonc.2021.624742

13,202 views
42 citations

Original Research

Published on 23 Feb 2021

Diagnostic Utility of IGF2BP1 and Its Targets as Potential Biomarkers in ETV6-RUNX1 Positive B-Cell Acute Lymphoblastic Leukemia

in Hematologic Malignancies

Gunjan Sharma
Elza Boby
Thakur Nidhi
Ayushi Jain
Jay Singh
Archna Singh
Parthaprasad Chattopadhyay
Sameer Bakhshi
Anita Chopra
Jayanth Kumar Palanichamy

Frontiers in Oncology

doi 10.3389/fonc.2021.588101

5,091 views
13 citations

Review

Published on 22 Feb 2021

Clinical Implications of Inflammation in Acute Myeloid Leukemia

in Hematologic Malignancies

Christian Récher

Frontiers in Oncology

doi 10.3389/fonc.2021.623952

18,481 views
56 citations

Original Research

Published on 22 Feb 2021

Identification and Validation of a Prognostic Gene Signature for Diffuse Large B-Cell Lymphoma Based on Tumor Microenvironment-Related Genes

in Hematologic Malignancies

Tao Pan
Yizi He
Huan Chen
Junfei Pei
Yajun Li
Ruolan Zeng
Jiliang Xia
Yilang Zuo
Liping Qin
Siwei Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.614211

6,321 views
19 citations

Original Research

Published on 19 Feb 2021

Treatment, Survival, and Prognosis of Advanced-Stage Natural Killer/T-Cell Lymphoma: An Analysis From the China Lymphoma Collaborative Group

in Hematologic Malignancies

Weiping Liu
Yong Yang
Shunan Qi
Ying Wang
Xia He
Liling Zhang
Baolin Qu
Liting Qian
Xiaorong Hou
Xueying Qiao

Frontiers in Oncology

doi 10.3389/fonc.2020.583050

12,879 views
24 citations

Correction

Published on 18 Feb 2021

Corrigendum: Trends in Incidence and Mortality of Waldenström Macroglobulinemia: A Population-Based Study

in Hematologic Malignancies

Xuejiao Yin
Lei Chen
Fengjuan Fan
Han Yan
Yuyang Zhang
Zhenli Huang
Chunyan Sun
Yu Hu

Frontiers in Oncology

doi 10.3389/fonc.2021.657016

2,788 views
1 citation

Review

Published on 18 Feb 2021

An Unconventional View of T Cell Reconstitution After Allogeneic Hematopoietic Cell Transplantation

in Hematologic Malignancies

Hana Andrlová
Marcel R. M. van den Brink
Kate A. Markey

Frontiers in Oncology

doi 10.3389/fonc.2020.608923

11,036 views
18 citations

Original Research

Published on 18 Feb 2021

Chemotherapy Plus Radiotherapy Versus Chemotherapy Alone for Patients With Peripheral T-Cell Lymphoma, Not Otherwise Specified

in Hematologic Malignancies

Zegeng Chen
He Huang
Xiaoqian Li
Xiaojie Fang
Zhao Wang
Huangming Hong
Zhihui Zhang
Qingqing Cai
Zhiming Li
Meiting Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.607145

4,770 views
14 citations

Original Research

Published on 18 Feb 2021

Prognostic Value of MicroRNA-20b in Acute Myeloid Leukemia

in Hematologic Malignancies

Zhiheng Cheng
Yifeng Dai
Wenhui Huang
Qingfu Zhong
Pei Zhu
Wenjuan Zhang
Zhihua Wu
Qing Lin
Huoyan Zhu
Longzhen Cui

Frontiers in Oncology

doi 10.3389/fonc.2020.553344

3,956 views
8 citations

2,071 articles

articles

HLC Pair Suppression as a Risk Factor for Bacterial Bloodstream Infections and Early Mortality in Newly Diagnosed Intact Immunoglobulin Multiple Myeloma Patients

Clinical Features and Prognoses of IgG4-Positive and IgG4-Negative Lacrimal Lymphomas

Circulating Plasma Cells as a Biomarker to Predict Newly Diagnosed Multiple Myeloma Prognosis: Developing Nomogram Prognostic Models

Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma

Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey

Prognostic Relevance of Expression of EMP1, CASP1, and NLRP3 Genes in Pediatric B-Lineage Acute Lymphoblastic Leukemia

Case Report: Asymmetric Bone Marrow Involvement in Patients With Acute Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Value of ctDNA in Hematological Malignancies (Lymphomas, Multiple Myeloma, Myelodysplastic Syndrome, and Leukemia): A Meta-Analysis

Comparison of Two Strategies for Prophylactic Donor Lymphocyte Infusion in Patients With Refractory/Relapsed Acute Leukemia

High Expression of CLEC11A Predicts Favorable Prognosis in Acute Myeloid Leukemia

Antinuclear Antibodies With a Nucleolar Pattern Are Associated With a Significant Reduction in the Overall Survival of Patients With Leukemia: A Retrospective Cohort Study

Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia

Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms

Haploidentical Stem Cell Transplantation With a Novel Conditioning Regimen in Older Patients: A Prospective Single-Arm Phase 2 Study

Evolving Chemotherapy Free Regimens for Acute Promyelocytic Leukemia

Hypomethylating Agents and Immunotherapy: Therapeutic Synergism in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Diagnostic Utility of IGF2BP1 and Its Targets as Potential Biomarkers in ETV6-RUNX1 Positive B-Cell Acute Lymphoblastic Leukemia

Clinical Implications of Inflammation in Acute Myeloid Leukemia

Identification and Validation of a Prognostic Gene Signature for Diffuse Large B-Cell Lymphoma Based on Tumor Microenvironment-Related Genes

Treatment, Survival, and Prognosis of Advanced-Stage Natural Killer/T-Cell Lymphoma: An Analysis From the China Lymphoma Collaborative Group

Corrigendum: Trends in Incidence and Mortality of Waldenström Macroglobulinemia: A Population-Based Study

An Unconventional View of T Cell Reconstitution After Allogeneic Hematopoietic Cell Transplantation

Chemotherapy Plus Radiotherapy Versus Chemotherapy Alone for Patients With Peripheral T-Cell Lymphoma, Not Otherwise Specified

Prognostic Value of MicroRNA-20b in Acute Myeloid Leukemia